Physician profile
Jay Shah
NPI 1538571997
$4,751.38
in general payments reported to CMS, 2019-2025
11 companies · $2,312 in 2025
The $2,312 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $481 · 2022: $1,492 · 2023: $20.11 · 2024: $447 · 2025: $2,312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,833 · Travel and Lodging: $946.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,833.03 |
| Travel and Lodging | $945.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $1,771.18 | 2025 | Angiovac |
| Medtronic, INC. | $1,696.58 | 2021-2024 | Corevalve Evolut R |
| Abbott Laboratories | $514.77 | 2021-2025 | Optis |
| Boston Scientific Corporation | $152.04 | 2024-2025 | General - Therapies, Ekosonic |
| Edwards Lifesciences Corporation | $132.87 | 2025 | Sapien 3 Ultra Resilia |
| Stryker Corporation | $116.64 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Inari Medical, INC. | $105.74 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Penumbra, INC. | $90.42 | 2025 | Indigo System |
| Abiomed | $86.40 | 2024 | Impella |
| Esperion Therapeutics, INC. | $64.63 | 2024-2025 | Nexletol |
| Atricure, INC. | $20.11 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.